Searchable abstracts of presentations at key conferences in endocrinology

ea0056p277 | Endocrine tumours and neoplasia | ECE2018

Somatostatin receptors 1 and 5 are novel markers of parathyroid tumor aggressiveness

Storvall Sara , Leijon Helena , Ryhanen Eeva , Louhimo Johanna , Haglund Caj , Schalin-Jantti Camilla , Arola Johanna

Background: Parathyroid carcinoma (PC) is a rare cause of primary hyperparathyroidism (PHPT). Distinguishing PC from other tumours underlying PHPT can be difficult and sometimes malignant diagnosis can be made only after recurrence of the disease. Atypical parathyroid adenomas (APA) have similar histological features as PC but lack signs of invasive growth. The expression of somatostatin receptors (SSTR) 1–5 in parathyroid tumours, commonly expressed in other neuroendocri...

ea0090p384 | Endocrine-related Cancer | ECE2023

Impact of SSTR PET/CT imaging on the follow-up of pancreatic NET in MEN1

Kostiainen Iiro , Majala Susanna , Schildt Jukka , Parviainen Helka , Kauhanen Saila , Seppanen Hanna , Miettinen Paivi , Matikainen Niina , Ryhanen Eeva , Schalin-Jantti Camilla

Introduction: In multiple endocrine neoplasia 1 (MEN1), the decreased life expectancy is related especially to pancreatic neuroendocrine tumors (panNETs). Timely diagnosis of potentially aggressive panNETs is the cornerstone of the follow-up in MEN1. Somatostatin receptor positron emission tomography (SSTR PET/CT) has a high accuracy in the detection of neuroendocrine tumors. The role of this imaging modality in early diagnosis and follow-up of MEN1-related panNETs is unclear....

ea0041ep138 | Calcium and Vitamin D metabolism | ECE2016

Increasing incidence of parathyroid carcinoma – a nationwide study

Ryhanen Eeva M , Leijon Helena , Metso Saara , Eloranta Eija , Korsoff Pirkko , Niskanen Leo , Ahtiainen Petteri , Kekalainen Paivi , Tamminen Marjo , Ristamaki Raija , Knutar Otto , Loyttyniemi Eliisa , Heiskanen Ilkka , Valimaki Matti J. , Haglund Caj , Arola Johanna , Schalin-Jantti Camilla

Introduction and design: Parathyroid carcinoma (PC) is a rare endocrine malignancy and the diagnosis is difficult. As the incidence seems to be increasing, we examined all cases diagnosed in our country during years 2000–2011 and compared the results to those of atypical parathyroid (AA; n=28) and parathyroid adenomas (A; n=72). All tissue specimens were re-examined.Results: In 2000–2011, 32 patients were diagnosed with PC in ...